logo
15:46 Jun 25

Onyx Biotec Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
37.05
-1.90 (-4.88%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Onyx Biotec Ltd. Financials

Onyx Biotec Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
37.05
-1.90 (-4.88%)
15:46 Jun 25
Quality
image/svg+xml

0/100
Not Eligible

Valuation
image/svg+xml

11/100
Expensive Valuation

Technical

45/100
Technically Neutral

Strength

4

Weakness

5

Opportunity

1

Threats

0

-0.38 %

ROE %

-0.22 %

ROA %

-0.12

EPS

30.56

BVPS

0.00 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
44.86 39.48 53.75 61.95 69.47
Operating Expenses +
39.23 35.03 45.46 51.6 66.08
Raw Material
26.47 21.3 36.17 38.61 51.12
Increase Decrease in Cost
0.05 -0.28 -0.43 0.53 0.54
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
8.62 10.48 6 8.64 8.61
Miscellaneous Expenses
4.09 3.53 3.72 3.82 5.81
Operating Profit
5.63 4.45 8.29 10.35 3.39
Other Income
0.12 0.13 0.13 1.17 0.44
Depreciation
1.45 1.49 2.25 3.05 3.05
Interest
0.51 0.55 2.11 1.99 1.21
Profit before tax and exceptio..
3.8 2.55 4.05 6.48 -0.42
Exceptional Items
0 0 0 0 0
PBT
3.8 2.55 4.05 6.48 -0.42
Provision for Taxation
0.44 0.7 1.02 1.52 -0.21
Net Profit
3.35 1.84 3.03 4.95 -0.21
NET Profit after MI
0 0 0 0 0
EPS
2.84 1.56 2.54 3.31 -0.12
Operating Profit Margin (%)
12.55 11.27 15.42 16.71 4.88
Net Profit Margin (%)
7.47 4.66 5.64 7.99 -0.3

Onyx Biotec Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Mar 2025 Sep 2025 Mar 2026
Promoter 65.10 65.10 65.10
FII 1.10 2.00 5.40
Public 2.40 2.30 2.40
Others 31.40 30.60 27.10
Shareholder Shares Holding %
Research 360 logo
Download Our App On: